Skip to main content
Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
3.490
-0.250 (-6.68%)
At close: Mar 9, 2026, 4:00 PM EDT
3.550
+0.060 (1.72%)
After-hours: Mar 9, 2026, 4:41 PM EDT

Nyxoah Revenue

Nyxoah had revenue of 1.97M EUR in the quarter ending September 30, 2025, with 55.77% growth. This brings the company's revenue in the last twelve months to 5.64M, up 10.96% year-over-year. In the year 2024, Nyxoah had annual revenue of 4.52M with 3.98% growth.

Revenue (ttm)
5.64M EUR
Revenue Growth
+10.96%
P/S Ratio
22.58
Revenue / Employee
30,714 EUR
Employees
184
Market Cap
149.39M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20244.52M173.00K3.98%
Dec 31, 20234.35M1.26M40.99%
Dec 31, 20223.08M2.23M261.97%
Dec 31, 2021852.00K783.00K1,134.78%
Dec 31, 202069.00K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AngioDynamics 307.31M
OraSure Technologies 115.02M
Sanara MedTech 101.88M
Pro-Dex 72.10M
KORU Medical Systems 39.07M
Utah Medical Products 38.52M
Stereotaxis 30.08M
Zentek 687.67K
Revenue Rankings

NYXH News

More News